Sorafenib Tosylate
Active substance: sorafenib tosylate
TABLET, FILM COATED · SORAFENIB TOSYLATE 200 mg/1
United StatesActive
Marketing holder: Mylan Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SORAFENIB TOSYLATE · 200 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5e13-7712-bddf-073e2c7df35f,01a12094-a8cf-7347-ac54-e6534ccdc535,01a12097-3853-7dd4-a1f8-c2f732e6f566;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0378-1201
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0378-1201 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0378-1201 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0378-1201 · Verified 2026-10-09 · open in source